DAIC

JANUARY 17, 2024

Christian Tesche (Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina and Department of Cardiology, Munich University Clinic, Ludwig-Maximilian-University).

Technology 111

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging 111

CardiacWire

MAY 18, 2024

Cardiovascular AI maintains a (distant) second largest share of FDA-cleared AI products, with 10% of total clearances (90), well below radiology’s 76% share (671). Cardiovascular AI actually makes up a larger 17.4% FFRCT, coronary plaque, etc). in 2020-2022, and 13.5% since the start of 2023.

Cardiovascular Imaging 69

Cardiovascular Imaging Plaque Innovation Ablation 69

CardiacWire

AUGUST 9, 2024

However, cardiovascular AI actually made up a larger 18% share of total H1 2024 clearances (19 devices) if you also count cardiovascular imaging AI products that the FDA technically categorized within its “Radiology” segment (e.g.

Innovation 52

Innovation TAVR Cardiovascular Imaging Plaque 52

DAIC

FEBRUARY 23, 2024

in European Association of Cardiovascular Imaging: Late Breaking Clinical Research and Trials. With Plaque Features Associated with False Positives. Derivation, Validation and Prognostic Assessment of an AI-Based Algorithm for Determination of Coronary Ischemia: The CREDENCE and PACIFIC Trial. Barcelona, Spain.

Ischemia 105

Ischemia Coronary Artery Disease Physiology Cardiovascular Imaging 105

Dr. Paddy Barrett

JUNE 21, 2024

Therefore, if someone presents with an event earlier than this age, they likely have been building up plaque for a considerable period prior to this. A CT CAC score of 0 means a person has no calcified coronary artery plaque and also means their risk of a heart attack over the next ten years is probably less than 2%. Genes (Basel).

Heart Disease 62

Heart Disease Heart Attack Heart attacks Coronary Artery Disease 62

Circulation: Cardiovascular Imaging

FEBRUARY 19, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 2 , Page e016178, February 1, 2024. BACKGROUND:It is not known whether there is a sex difference in the association between perivascular inflammation and plaque vulnerability. All images were analyzed at a core laboratory. plaques per patient). versus 46.9%,P=0.002

Plaque 73

Plaque Coronary Artery Disease Laboratory Cardiovascular Imaging 73

Circulation: Cardiovascular Imaging

JANUARY 11, 2024

Circulation: Cardiovascular Imaging, Ahead of Print. A decrease in the percentage of unstable core (fibro-fatty+necrotic plaque; from 14.1 [7.9–22.3] BACKGROUND:Intensive lipid-lowering therapy may induce coronary atherosclerosis regression. The global coronary PB changed from 34.6% (32.5%–36.8%) 36.8%) at entry to 30.4% (27.4%–33.4%)

Plaque 40

Plaque Atherosclerosis Cardiovascular Imaging Cardiovascular Disease 40

DAIC

FEBRUARY 13, 2024

25, 2024 in the European Heart Journal Cardiovascular Imaging. 25, 2024 in the European Heart Journal Cardiovascular Imaging 1. 25, 2024 in the European Heart Journal Cardiovascular Imaging 1. Presented at the European Association of Cardiovascular Imaging: Late Breaking Clinical Research and Trials.

Coronary Artery Disease 103

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging 103

Circulation: Cardiovascular Imaging

FEBRUARY 19, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 2 , Page e016057, February 1, 2024. 18F-flourodeoxyglucose resting amygdalar uptake, an imaging biomarker of stress-related neural activity, coronary inflammation (fat attenuation index), and high-risk plaque characteristics were assessed by coronary computed tomography angiography.

Atherosclerosis 40

Atherosclerosis Plaque Coronary Artery Disease Biomarkers 40

Open Heart

APRIL 18, 2022

Baseline tissue characterisation includes the morphological description of culprit lesion plaque characteristics and thrombus as assessed with HD-IVUS. Study findings will be submitted to international peer-reviewed journals in the field of cardiovascular imaging and interventions and will be presented at international scientific meetings.

Ultrasound 52

Ultrasound Myocardial Infarction Cardiovascular Imaging Plaque 52